Neoadjuvant immune checkpoint blockade in women with mismatch repair deficient endometrial cancer: a phase I study.
Eerkens AL, Brummel K, Vledder A, Paijens ST, Requesens M, Loiero D, van Rooij N, Plat A, Haan FJ, Klok P, Yigit R, Roelofsen T, de Lange NM, Klomp R, Church D, Ter Elst A, Wardenaar R, Spierings D, Foijer F, Koelzer VH, Bosse T, Bart J, Jalving M, Reyners AKL, de Bruyn M, Nijman HW.
Eerkens AL, et al. Among authors: van rooij n.
Nat Commun. 2024 Sep 3;15(1):7695. doi: 10.1038/s41467-024-52098-8.
Nat Commun. 2024.
PMID: 39227583
Free PMC article.
Clinical Trial.